Global Oncology Molecular Diagnostic Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Oncology Molecular Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Instruments
  • 1.2.3 Reagents
• 1.3 Market by Application
  • 1.3.1 Global Oncology Molecular Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Breast Cancer
  • 1.3.3 Prostate Cancer
  • 1.3.4 Colorectal Cancer
  • 1.3.5 Cervical Cancer
  • 1.3.6 Liver Cancer
  • 1.3.7 Lung Cancer
  • 1.3.8 Blood Cancer
  • 1.3.9 Kidney Cancer
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Oncology Molecular Diagnostic Market Perspective (2017-2028)
• 2.2 Oncology Molecular Diagnostic Growth Trends by Region
  • 2.2.1 Oncology Molecular Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Oncology Molecular Diagnostic Historic Market Size by Region (2017-2022)
  • 2.2.3 Oncology Molecular Diagnostic Forecasted Market Size by Region (2023-2028)
• 2.3 Oncology Molecular Diagnostic Market Dynamics
  • 2.3.1 Oncology Molecular Diagnostic Industry Trends
  • 2.3.2 Oncology Molecular Diagnostic Market Drivers
  • 2.3.3 Oncology Molecular Diagnostic Market Challenges
  • 2.3.4 Oncology Molecular Diagnostic Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Oncology Molecular Diagnostic Players by Revenue
  • 3.1.1 Global Top Oncology Molecular Diagnostic Players by Revenue (2017-2022)
  • 3.1.2 Global Oncology Molecular Diagnostic Revenue Market Share by Players (2017-2022)
• 3.2 Global Oncology Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Oncology Molecular Diagnostic Revenue
• 3.4 Global Oncology Molecular Diagnostic Market Concentration Ratio
  • 3.4.1 Global Oncology Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Oncology Molecular Diagnostic Revenue in 2021
• 3.5 Oncology Molecular Diagnostic Key Players Head office and Area Served
• 3.6 Key Players Oncology Molecular Diagnostic Product Solution and Service
• 3.7 Date of Enter into Oncology Molecular Diagnostic Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Molecular Diagnostic Breakdown Data by Type

• 4.1 Global Oncology Molecular Diagnostic Historic Market Size by Type (2017-2022)
• 4.2 Global Oncology Molecular Diagnostic Forecasted Market Size by Type (2023-2028)

5 Oncology Molecular Diagnostic Breakdown Data by Application

• 5.1 Global Oncology Molecular Diagnostic Historic Market Size by Application (2017-2022)
• 5.2 Global Oncology Molecular Diagnostic Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Oncology Molecular Diagnostic Market Size (2017-2028)
• 6.2 North America Oncology Molecular Diagnostic Market Size by Type
  • 6.2.1 North America Oncology Molecular Diagnostic Market Size by Type (2017-2022)
  • 6.2.2 North America Oncology Molecular Diagnostic Market Size by Type (2023-2028)
  • 6.2.3 North America Oncology Molecular Diagnostic Market Share by Type (2017-2028)
• 6.3 North America Oncology Molecular Diagnostic Market Size by Application
  • 6.3.1 North America Oncology Molecular Diagnostic Market Size by Application (2017-2022)
  • 6.3.2 North America Oncology Molecular Diagnostic Market Size by Application (2023-2028)
  • 6.3.3 North America Oncology Molecular Diagnostic Market Share by Application (2017-2028)
• 6.4 North America Oncology Molecular Diagnostic Market Size by Country
  • 6.4.1 North America Oncology Molecular Diagnostic Market Size by Country (2017-2022)
  • 6.4.2 North America Oncology Molecular Diagnostic Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Oncology Molecular Diagnostic Market Size (2017-2028)
• 7.2 Europe Oncology Molecular Diagnostic Market Size by Type
  • 7.2.1 Europe Oncology Molecular Diagnostic Market Size by Type (2017-2022)
  • 7.2.2 Europe Oncology Molecular Diagnostic Market Size by Type (2023-2028)
  • 7.2.3 Europe Oncology Molecular Diagnostic Market Share by Type (2017-2028)
• 7.3 Europe Oncology Molecular Diagnostic Market Size by Application
  • 7.3.1 Europe Oncology Molecular Diagnostic Market Size by Application (2017-2022)
  • 7.3.2 Europe Oncology Molecular Diagnostic Market Size by Application (2023-2028)
  • 7.3.3 Europe Oncology Molecular Diagnostic Market Share by Application (2017-2028)
• 7.4 Europe Oncology Molecular Diagnostic Market Size by Country
  • 7.4.1 Europe Oncology Molecular Diagnostic Market Size by Country (2017-2022)
  • 7.4.2 Europe Oncology Molecular Diagnostic Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Oncology Molecular Diagnostic Market Size (2017-2028)
• 8.2 Asia-Pacific Oncology Molecular Diagnostic Market Size by Type
  • 8.2.1 Asia-Pacific Oncology Molecular Diagnostic Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Oncology Molecular Diagnostic Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Oncology Molecular Diagnostic Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Oncology Molecular Diagnostic Market Size by Application
  • 8.3.1 Asia-Pacific Oncology Molecular Diagnostic Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Oncology Molecular Diagnostic Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Oncology Molecular Diagnostic Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Oncology Molecular Diagnostic Market Size by Region
  • 8.4.1 Asia-Pacific Oncology Molecular Diagnostic Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Oncology Molecular Diagnostic Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Oncology Molecular Diagnostic Market Size (2017-2028)
• 9.2 Latin America Oncology Molecular Diagnostic Market Size by Type
  • 9.2.1 Latin America Oncology Molecular Diagnostic Market Size by Type (2017-2022)
  • 9.2.2 Latin America Oncology Molecular Diagnostic Market Size by Type (2023-2028)
  • 9.2.3 Latin America Oncology Molecular Diagnostic Market Share by Type (2017-2028)
• 9.3 Latin America Oncology Molecular Diagnostic Market Size by Application
  • 9.3.1 Latin America Oncology Molecular Diagnostic Market Size by Application (2017-2022)
  • 9.3.2 Latin America Oncology Molecular Diagnostic Market Size by Application (2023-2028)
  • 9.3.3 Latin America Oncology Molecular Diagnostic Market Share by Application (2017-2028)
• 9.4 Latin America Oncology Molecular Diagnostic Market Size by Country
  • 9.4.1 Latin America Oncology Molecular Diagnostic Market Size by Country (2017-2022)
  • 9.4.2 Latin America Oncology Molecular Diagnostic Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Oncology Molecular Diagnostic Market Size (2017-2028)
• 10.2 Middle East & Africa Oncology Molecular Diagnostic Market Size by Type
  • 10.2.1 Middle East & Africa Oncology Molecular Diagnostic Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Oncology Molecular Diagnostic Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Oncology Molecular Diagnostic Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Oncology Molecular Diagnostic Market Size by Application
  • 10.3.1 Middle East & Africa Oncology Molecular Diagnostic Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Oncology Molecular Diagnostic Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Oncology Molecular Diagnostic Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Oncology Molecular Diagnostic Market Size by Country
  • 10.4.1 Middle East & Africa Oncology Molecular Diagnostic Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Oncology Molecular Diagnostic Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Abbott
  • 11.1.1 Abbott Company Details
  • 11.1.2 Abbott Business Overview
  • 11.1.3 Abbott Oncology Molecular Diagnostic Introduction
  • 11.1.4 Abbott Revenue in Oncology Molecular Diagnostic Business (2017-2022)
  • 11.1.5 Abbott Recent Developments
• 11.2 Bayer Healthcare
  • 11.2.1 Bayer Healthcare Company Details
  • 11.2.2 Bayer Healthcare Business Overview
  • 11.2.3 Bayer Healthcare Oncology Molecular Diagnostic Introduction
  • 11.2.4 Bayer Healthcare Revenue in Oncology Molecular Diagnostic Business (2017-2022)
  • 11.2.5 Bayer Healthcare Recent Developments
• 11.3 Beckton Dickinson
  • 11.3.1 Beckton Dickinson Company Details
  • 11.3.2 Beckton Dickinson Business Overview
  • 11.3.3 Beckton Dickinson Oncology Molecular Diagnostic Introduction
  • 11.3.4 Beckton Dickinson Revenue in Oncology Molecular Diagnostic Business (2017-2022)
  • 11.3.5 Beckton Dickinson Recent Developments
• 11.4 Cepheid
  • 11.4.1 Cepheid Company Details
  • 11.4.2 Cepheid Business Overview
  • 11.4.3 Cepheid Oncology Molecular Diagnostic Introduction
  • 11.4.4 Cepheid Revenue in Oncology Molecular Diagnostic Business (2017-2022)
  • 11.4.5 Cepheid Recent Developments
• 11.5 Dako
  • 11.5.1 Dako Company Details
  • 11.5.2 Dako Business Overview
  • 11.5.3 Dako Oncology Molecular Diagnostic Introduction
  • 11.5.4 Dako Revenue in Oncology Molecular Diagnostic Business (2017-2022)
  • 11.5.5 Dako Recent Developments
• 11.6 Hologic
  • 11.6.1 Hologic Company Details
  • 11.6.2 Hologic Business Overview
  • 11.6.3 Hologic Oncology Molecular Diagnostic Introduction
  • 11.6.4 Hologic Revenue in Oncology Molecular Diagnostic Business (2017-2022)
  • 11.6.5 Hologic Recent Developments
• 11.7 Qiagen
  • 11.7.1 Qiagen Company Details
  • 11.7.2 Qiagen Business Overview
  • 11.7.3 Qiagen Oncology Molecular Diagnostic Introduction
  • 11.7.4 Qiagen Revenue in Oncology Molecular Diagnostic Business (2017-2022)
  • 11.7.5 Qiagen Recent Developments
• 11.8 Roche
  • 11.8.1 Roche Company Details
  • 11.8.2 Roche Business Overview
  • 11.8.3 Roche Oncology Molecular Diagnostic Introduction
  • 11.8.4 Roche Revenue in Oncology Molecular Diagnostic Business (2017-2022)
  • 11.8.5 Roche Recent Developments
• 11.9 Siemens Healthineers
  • 11.9.1 Siemens Healthineers Company Details
  • 11.9.2 Siemens Healthineers Business Overview
  • 11.9.3 Siemens Healthineers Oncology Molecular Diagnostic Introduction
  • 11.9.4 Siemens Healthineers Revenue in Oncology Molecular Diagnostic Business (2017-2022)
  • 11.9.5 Siemens Healthineers Recent Developments
• 11.10 Sysmex
  • 11.10.1 Sysmex Company Details
  • 11.10.2 Sysmex Business Overview
  • 11.10.3 Sysmex Oncology Molecular Diagnostic Introduction
  • 11.10.4 Sysmex Revenue in Oncology Molecular Diagnostic Business (2017-2022)
  • 11.10.5 Sysmex Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Oncology Molecular Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Instruments
• Table 3. Key Players of Reagents
• Table 4. Global Oncology Molecular Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 5. Global Oncology Molecular Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 6. Global Oncology Molecular Diagnostic Market Size by Region (2017-2022) & (US$ Million)
• Table 7. Global Oncology Molecular Diagnostic Market Share by Region (2017-2022)
• Table 8. Global Oncology Molecular Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 9. Global Oncology Molecular Diagnostic Market Share by Region (2023-2028)
• Table 10. Oncology Molecular Diagnostic Market Trends
• Table 11. Oncology Molecular Diagnostic Market Drivers
• Table 12. Oncology Molecular Diagnostic Market Challenges
• Table 13. Oncology Molecular Diagnostic Market Restraints
• Table 14. Global Oncology Molecular Diagnostic Revenue by Players (2017-2022) & (US$ Million)
• Table 15. Global Oncology Molecular Diagnostic Revenue Share by Players (2017-2022)
• Table 16. Global Top Oncology Molecular Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Molecular Diagnostic as of 2021)
• Table 17. Ranking of Global Top Oncology Molecular Diagnostic Companies by Revenue (US$ Million) in 2021
• Table 18. Global 5 Largest Players Market Share by Oncology Molecular Diagnostic Revenue (CR5 and HHI) & (2017-2022)
• Table 19. Key Players Headquarters and Area Served
• Table 20. Key Players Oncology Molecular Diagnostic Product Solution and Service
• Table 21. Date of Enter into Oncology Molecular Diagnostic Market
• Table 22. Mergers & Acquisitions, Expansion Plans
• Table 23. Global Oncology Molecular Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 24. Global Oncology Molecular Diagnostic Revenue Market Share by Type (2017-2022)
• Table 25. Global Oncology Molecular Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 26. Global Oncology Molecular Diagnostic Revenue Market Share by Type (2023-2028)
• Table 27. Global Oncology Molecular Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 28. Global Oncology Molecular Diagnostic Revenue Share by Application (2017-2022)
• Table 29. Global Oncology Molecular Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 30. Global Oncology Molecular Diagnostic Revenue Share by Application (2023-2028)
• Table 31. North America Oncology Molecular Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 32. North America Oncology Molecular Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 33. North America Oncology Molecular Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 34. North America Oncology Molecular Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 35. North America Oncology Molecular Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 36. North America Oncology Molecular Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 37. Europe Oncology Molecular Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 38. Europe Oncology Molecular Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 39. Europe Oncology Molecular Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 40. Europe Oncology Molecular Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 41. Europe Oncology Molecular Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 42. Europe Oncology Molecular Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 43. Asia Pacific Oncology Molecular Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 44. Asia Pacific Oncology Molecular Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Oncology Molecular Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Oncology Molecular Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Oncology Molecular Diagnostic Market Size by Region (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Oncology Molecular Diagnostic Market Size by Region (2023-2028) & (US$ Million)
• Table 49. Latin America Oncology Molecular Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 50. Latin America Oncology Molecular Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 51. Latin America Oncology Molecular Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 52. Latin America Oncology Molecular Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 53. Latin America Oncology Molecular Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 54. Latin America Oncology Molecular Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 55. Middle East and Africa Oncology Molecular Diagnostic Market Size by Type (2017-2022) & (US$ Million)
• Table 56. Middle East and Africa Oncology Molecular Diagnostic Market Size by Type (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Oncology Molecular Diagnostic Market Size by Application (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Oncology Molecular Diagnostic Market Size by Application (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Oncology Molecular Diagnostic Market Size by Country (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Oncology Molecular Diagnostic Market Size by Country (2023-2028) & (US$ Million)
• Table 61. Abbott Company Details
• Table 62. Abbott Business Overview
• Table 63. Abbott Oncology Molecular Diagnostic Product
• Table 64. Abbott Revenue in Oncology Molecular Diagnostic Business (2017-2022) & (US$ Million)
• Table 65. Abbott Recent Developments
• Table 66. Bayer Healthcare Company Details
• Table 67. Bayer Healthcare Business Overview
• Table 68. Bayer Healthcare Oncology Molecular Diagnostic Product
• Table 69. Bayer Healthcare Revenue in Oncology Molecular Diagnostic Business (2017-2022) & (US$ Million)
• Table 70. Bayer Healthcare Recent Developments
• Table 71. Beckton Dickinson Company Details
• Table 72. Beckton Dickinson Business Overview
• Table 73. Beckton Dickinson Oncology Molecular Diagnostic Product
• Table 74. Beckton Dickinson Revenue in Oncology Molecular Diagnostic Business (2017-2022) & (US$ Million)
• Table 75. Beckton Dickinson Recent Developments
• Table 76. Cepheid Company Details
• Table 77. Cepheid Business Overview
• Table 78. Cepheid Oncology Molecular Diagnostic Product
• Table 79. Cepheid Revenue in Oncology Molecular Diagnostic Business (2017-2022) & (US$ Million)
• Table 80. Cepheid Recent Developments
• Table 81. Dako Company Details
• Table 82. Dako Business Overview
• Table 83. Dako Oncology Molecular Diagnostic Product
• Table 84. Dako Revenue in Oncology Molecular Diagnostic Business (2017-2022) & (US$ Million)
• Table 85. Dako Recent Developments
• Table 86. Hologic Company Details
• Table 87. Hologic Business Overview
• Table 88. Hologic Oncology Molecular Diagnostic Product
• Table 89. Hologic Revenue in Oncology Molecular Diagnostic Business (2017-2022) & (US$ Million)
• Table 90. Hologic Recent Developments
• Table 91. Qiagen Company Details
• Table 92. Qiagen Business Overview
• Table 93. Qiagen Oncology Molecular Diagnostic Product
• Table 94. Qiagen Revenue in Oncology Molecular Diagnostic Business (2017-2022) & (US$ Million)
• Table 95. Qiagen Recent Developments
• Table 96. Roche Company Details
• Table 97. Roche Business Overview
• Table 98. Roche Oncology Molecular Diagnostic Product
• Table 99. Roche Revenue in Oncology Molecular Diagnostic Business (2017-2022) & (US$ Million)
• Table 100. Roche Recent Developments
• Table 101. Siemens Healthineers Company Details
• Table 102. Siemens Healthineers Business Overview
• Table 103. Siemens Healthineers Oncology Molecular Diagnostic Product
• Table 104. Siemens Healthineers Revenue in Oncology Molecular Diagnostic Business (2017-2022) & (US$ Million)
• Table 105. Siemens Healthineers Recent Developments
• Table 106. Sysmex Company Details
• Table 107. Sysmex Business Overview
• Table 108. Sysmex Oncology Molecular Diagnostic Product
• Table 109. Sysmex Revenue in Oncology Molecular Diagnostic Business (2017-2022) & (US$ Million)
• Table 110. Sysmex Recent Developments
• Table 111. Research Programs/Design for This Report
• Table 112. Key Data Information from Secondary Sources
• Table 113. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Oncology Molecular Diagnostic Market Share by Type: 2021 VS 2028
• Figure 2. Instruments Features
• Figure 3. Reagents Features
• Figure 4. Global Oncology Molecular Diagnostic Market Share by Application: 2021 VS 2028
• Figure 5. Breast Cancer Case Studies
• Figure 6. Prostate Cancer Case Studies
• Figure 7. Colorectal Cancer Case Studies
• Figure 8. Cervical Cancer Case Studies
• Figure 9. Liver Cancer Case Studies
• Figure 10. Lung Cancer Case Studies
• Figure 11. Blood Cancer Case Studies
• Figure 12. Kidney Cancer Case Studies
• Figure 13. Oncology Molecular Diagnostic Report Years Considered
• Figure 14. Global Oncology Molecular Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 15. Global Oncology Molecular Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 16. Global Oncology Molecular Diagnostic Market Share by Region: 2021 VS 2028
• Figure 17. Global Oncology Molecular Diagnostic Market Share by Players in 2021
• Figure 18. Global Top Oncology Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Molecular Diagnostic as of 2021)
• Figure 19. The Top 10 and 5 Players Market Share by Oncology Molecular Diagnostic Revenue in 2021
• Figure 20. North America Oncology Molecular Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 21. North America Oncology Molecular Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 22. North America Oncology Molecular Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 23. North America Oncology Molecular Diagnostic Market Size Share by Country (2017-2028)
• Figure 24. United States Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 25. Canada Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 26. Europe Oncology Molecular Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 27. Europe Oncology Molecular Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 28. Europe Oncology Molecular Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 29. Europe Oncology Molecular Diagnostic Market Size Share by Country (2017-2028)
• Figure 30. Germany Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. France Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. U.K. Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. Italy Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 34. Russia Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 35. Nordic Countries Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 36. Asia-Pacific Oncology Molecular Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 37. Asia Pacific Oncology Molecular Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 38. Asia Pacific Oncology Molecular Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 39. Asia Pacific Oncology Molecular Diagnostic Market Size Share by Region (2017-2028)
• Figure 40. China Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Japan Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. South Korea Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 43. Southeast Asia Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 44. India Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 45. Australia Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 46. Latin America Oncology Molecular Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 47. Latin America Oncology Molecular Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 48. Latin America Oncology Molecular Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 49. Latin America Oncology Molecular Diagnostic Market Size Share by Country (2017-2028)
• Figure 50. Mexico Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 51. Brazil Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 52. Middle East & Africa Oncology Molecular Diagnostic Market Size YoY (2017-2028) & (US$ Million)
• Figure 53. Middle East and Africa Oncology Molecular Diagnostic Market Size Market Share by Type (2017-2028)
• Figure 54. Middle East and Africa Oncology Molecular Diagnostic Market Size Market Share by Application (2017-2028)
• Figure 55. Middle East and Africa Oncology Molecular Diagnostic Market Size Share by Country (2017-2028)
• Figure 56. Turkey Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 57. Saudi Arabia Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 58. UAE Oncology Molecular Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 59. Abbott Revenue Growth Rate in Oncology Molecular Diagnostic Business (2017-2022)
• Figure 60. Bayer Healthcare Revenue Growth Rate in Oncology Molecular Diagnostic Business (2017-2022)
• Figure 61. Beckton Dickinson Revenue Growth Rate in Oncology Molecular Diagnostic Business (2017-2022)
• Figure 62. Cepheid Revenue Growth Rate in Oncology Molecular Diagnostic Business (2017-2022)
• Figure 63. Dako Revenue Growth Rate in Oncology Molecular Diagnostic Business (2017-2022)
• Figure 64. Hologic Revenue Growth Rate in Oncology Molecular Diagnostic Business (2017-2022)
• Figure 65. Qiagen Revenue Growth Rate in Oncology Molecular Diagnostic Business (2017-2022)
• Figure 66. Roche Revenue Growth Rate in Oncology Molecular Diagnostic Business (2017-2022)
• Figure 67. Siemens Healthineers Revenue Growth Rate in Oncology Molecular Diagnostic Business (2017-2022)
• Figure 68. Sysmex Revenue Growth Rate in Oncology Molecular Diagnostic Business (2017-2022)
• Figure 69. Bottom-up and Top-down Approaches for This Report
• Figure 70. Data Triangulation
• Figure 71. Key Executives Interviewed